Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. Its products include general medicines, B-Lactam, cephalosporins, anti-retroviral and veterinary medicines. The company was founded by Ramesh Desai on September 3, 1992 and is headquartered in Vadodara, India.
Bharat Parenterals Dividend Announcement
• Bharat Parenterals announced a annually dividend of ₹1.00 per ordinary share which will be made payable on 2024-08-01. Ex dividend date: 2024-06-25
• Bharat Parenterals annual dividend for 2024 was ₹1.00
• Bharat Parenterals annual dividend for 2023 was ₹0.75
• Bharat Parenterals's trailing twelve-month (TTM) dividend yield is 0.06%
Bharat Parenterals Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-06-25 | ₹1.00 | annually | 2024-08-01 |
| 2023-09-25 | ₹0.75 | annually | 2023-10-30 |
Bharat Parenterals Dividend per year
Bharat Parenterals Dividend Yield
Bharat Parenterals current trailing twelve-month (TTM) dividend yield is 0.06%. Interested in purchasing Bharat Parenterals stock? Use our calculator to estimate your expected dividend yield:
Bharat Parenterals Financial Ratios
P/E ratio-398.29
PEG ratio-8.30
P/B ratio3.87
ROE-1.16%
Payout ratio0.00%
Current ratio1.80
Quick ratio1.55
Cash Ratio0.26
Bharat Parenterals Dividend FAQ
Does Bharat Parenterals stock pay dividends?
Bharat Parenterals does not currently pay dividends to its shareholders.
Has Bharat Parenterals ever paid a dividend?
No, Bharat Parenterals has no a history of paying dividends to its shareholders. Bharat Parenterals is not known for its dividend payments.
Why doesn't Bharat Parenterals pay dividends?
There are several potential reasons why Bharat Parenterals would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bharat Parenterals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bharat Parenterals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bharat Parenterals a dividend aristocrat?
Bharat Parenterals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bharat Parenterals a dividend king?
Bharat Parenterals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bharat Parenterals a dividend stock?
No, Bharat Parenterals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bharat Parenterals stocks?
To buy Bharat Parenterals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Bharat Parenterals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Bharat Parenterals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.